mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0015 |
1 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.00089 |
1 |